<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Research Reports</title>
	<atom:link href="http://pharmaexecnews.com/category/biotechnology/research-reports-biotechnology/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Researchers Gain More Insight on How Thalidomide Leads to Birth Defects</title>
		<link>http://pharmaexecnews.com/biotechnology/researchers-gain-insight-thalidomide-leads-birth-defects/</link>
		<comments>http://pharmaexecnews.com/biotechnology/researchers-gain-insight-thalidomide-leads-birth-defects/#comments</comments>
		<pubDate>Wed, 27 Apr 2011 08:00:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11518</guid>
		<description><![CDATA[Thalidomide was introduced as a sedative drug in the late 1950s. In 1961, it was withdrawn due to teratogenicity and neuropathy. There is now a growing clinical interest in thalidomide, and it is introduced as an immunomodulatory agent used primarily, combined with dexamethasone, to treat multiple myeloma. The drug is a potent teratogen in zebrafish, [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/researchers-gain-insight-thalidomide-leads-birth-defects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Plan of Attack Against Breast Cancer Stem Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/plan-attack-breast-cancer-stem-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/plan-attack-breast-cancer-stem-cells/#comments</comments>
		<pubDate>Fri, 21 Jan 2011 08:00:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Breast cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11094</guid>
		<description><![CDATA[It was Max Wicha of the University of Michigan who first identified breast cancer stem cells back in 2003. Now, Wicha and colleagues have identified a possible way to attack these cells, which are responsible for a tumor&#8217;s growth and spread.

The researchers found that breast cancer stem cells are regulated by a type of cell [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/plan-attack-breast-cancer-stem-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Burrill Predicts Big Surge in Biotech Buyouts for 2011</title>
		<link>http://pharmaexecnews.com/biotechnology/burrill-predicts-big-surge-biotech-buyouts-2011/</link>
		<comments>http://pharmaexecnews.com/biotechnology/burrill-predicts-big-surge-biotech-buyouts-2011/#comments</comments>
		<pubDate>Mon, 10 Jan 2011 08:00:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Deals and Mergers]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11057</guid>
		<description><![CDATA[Big upfront fees are out. Milestones are in. Partnerships will stay hot. The IPO window will stay open, despite a lackluster record in 2010. And investor confidence will grow, helping public biotech companies outperform the general market.

Those are some of the broad-stroke predictions being made by the self-styled biotech &#8216;guru&#8217; Steven Burrill, who regularly commands [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/burrill-predicts-big-surge-biotech-buyouts-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists Peer into the Future of Stem Cell Biology</title>
		<link>http://pharmaexecnews.com/biotechnology/scientists-peer-future-stem-cell-biology/</link>
		<comments>http://pharmaexecnews.com/biotechnology/scientists-peer-future-stem-cell-biology/#comments</comments>
		<pubDate>Thu, 06 Jan 2011 08:00:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11048</guid>
		<description><![CDATA[Remarkable progress in understanding how stem cell biology works has been reported by a team of leading scientists, directed by experts at UC Santa Barbara. Stem cell biology is making waves around the world with great hope for the eventual repair of parts of the body. While many scientists see these breakthroughs as viable, there [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/scientists-peer-future-stem-cell-biology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bacteria Provide Example of One of Nature&#8217;s First Immune Systems</title>
		<link>http://pharmaexecnews.com/biotechnology/bacteria-provide-natures-immune-systems/</link>
		<comments>http://pharmaexecnews.com/biotechnology/bacteria-provide-natures-immune-systems/#comments</comments>
		<pubDate>Tue, 04 Jan 2011 08:00:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[dna]]></category>
		<category><![CDATA[dna sequence]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11038</guid>
		<description><![CDATA[Studying how bacteria incorporate foreign DNA from invading viruses into their own regulatory processes, Thomas Wood, professor in the Artie McFerrin Department of Chemical Engineering at Texas  A&#38;M University, is uncovering the secrets of one of nature&#8217;s most primitive immune systems.

His findings, which appear in Nature Communications, shed light on how bacteria have throughout [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/bacteria-provide-natures-immune-systems/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World&#8217;s First Stem Cell Trial for Strokes</title>
		<link>http://pharmaexecnews.com/biotechnology/worlds-stem-cell-trial-strokes/</link>
		<comments>http://pharmaexecnews.com/biotechnology/worlds-stem-cell-trial-strokes/#comments</comments>
		<pubDate>Tue, 28 Dec 2010 08:00:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11014</guid>
		<description><![CDATA[The UK&#8217;s ReNeuron has been given a regulatory green light to launch the world&#8217;s first human trial of a stem cell therapy for strokes.  Beginning in the second quarter of this year, researchers for the biotech will begin to see exactly how stroke victims respond to the neural stem cell therapy, which researchers say could [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/worlds-stem-cell-trial-strokes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First HIV &#8220;Cure&#8221; Comes with a Very Big Catch</title>
		<link>http://pharmaexecnews.com/biotechnology/hiv-cure-big-catch/</link>
		<comments>http://pharmaexecnews.com/biotechnology/hiv-cure-big-catch/#comments</comments>
		<pubDate>Wed, 22 Dec 2010 08:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[understanding stem cell research]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11003</guid>
		<description><![CDATA[In a rare victory against AIDS, German scientists say that three years after a unique stem cell transplant was tried on a patient, &#8220;cure of HIV has been achieved in this&#8221; man. This is the first time anyone has been pronounced cured of the disease. But as New Scientist notes, their radical therapy strategy offers [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/hiv-cure-big-catch/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech start-Up Tackles Cancer Stem Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/biotech-startup-tackles-cancer-stem-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biotech-startup-tackles-cancer-stem-cells/#comments</comments>
		<pubDate>Fri, 17 Dec 2010 08:00:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10982</guid>
		<description><![CDATA[A fledgling biotech company is pursuing some of the research into cancer stem cells undertaken by Robert Weinberg at the Massachusetts Institute of Technology and the Whitehead Institute for Biomedical Research. Verastem raised $16 million a few weeks ago with an eye on developing new treatments tailored for fighting the unique stem cells, which are [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biotech-startup-tackles-cancer-stem-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nanotechnology Promises Big Benefits for Cancer Patients</title>
		<link>http://pharmaexecnews.com/biotechnology/nanotechnology-promises-big-benefits-cancer-patients/</link>
		<comments>http://pharmaexecnews.com/biotechnology/nanotechnology-promises-big-benefits-cancer-patients/#comments</comments>
		<pubDate>Mon, 29 Nov 2010 08:00:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[micro technology]]></category>
		<category><![CDATA[nano]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10923</guid>
		<description><![CDATA[A $145-million U.S. Federal Government effort to harness the power of nanotechnology to improve the diagnosis, treatment, and prevention of cancer is producing innovations that will radically improve care for the disease. That&#8217;s the conclusion of an update on the status of the program, called the National Cancer Institute Alliance for Nanotechnology in Cancer. It [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/nanotechnology-promises-big-benefits-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Modulating Protein Could Help Control Alzheimer&#8217;s Disease</title>
		<link>http://pharmaexecnews.com/biotechnology/modulating-protein-control-alzheimers-disease/</link>
		<comments>http://pharmaexecnews.com/biotechnology/modulating-protein-control-alzheimers-disease/#comments</comments>
		<pubDate>Mon, 22 Nov 2010 08:00:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10906</guid>
		<description><![CDATA[A protein known to exist in the brain for more than 30 years, called 5-lipoxygenase, has been found to play a regulatory role in the formation of the amyloid beta in the brain, the major component of plaques implicated in the development of Alzheimer&#8217;s disease, according to researchers at Temple University&#8217;s School of Medicine.

The researchers [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/modulating-protein-control-alzheimers-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

